Differences in benefits of office based opioid treatment: Secondary analyses across sub‐groups in the PROUD randomized controlled implementation trial

Documenti analoghi

• Distinguishing chronic disease profiles and cause of death attribution in opioid and or stimulant toxicity deaths to inform overdose prevention efforts
  di: Heather Palis, et al.
  Pubblicazione: (2026)
• Association between change in alcohol use reported during routine healthcare screening and change in subsequent hospitalization: A retrospective cohort study
  di: Helen E. Jack, et al.
  Pubblicazione: (2025)
• Clinical factors linked to xylazine exposure in emergency department patients with illicit opioid overdose
  di: Jennifer S. Love, et al.
  Pubblicazione: (2026)
• A cost–benefit analysis of the implementation and scale‐up of harm reduction interventions in the Australian Capital Territory
  di: Anna L. Bowring, et al.
  Pubblicazione: (2026)
• Screening for addiction in the dental office: The bottom line
  di: Carrigan L. Parish, et al.
  Pubblicazione: (2026)